The Illumina Accelerator is open to early-stage companies working on innovative solutions in genomics, biotechnology, and life sciences. Startups that have a compelling vision and the potential to make a significant impact in fields such as cancer research are encouraged to apply. The selection process is competitive, with a focus on the scientific merit, commercial potential, and the strength of the founding team.
